Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    The Estate by sbe Announces Today: The Future of Living with Over $1 Billion in Branded Luxury Residential Development

    November 18, 2026

    IGEL Reaches Unicorn Status with Strategic Investment from Vitruvian Partners to Accelerate Growth of its Endpoint Security and Cyber Resilience Endpoint Platform for Enterprise

    November 18, 2026

    Andela is Named a Select Tier Services Partner in the Claude Partner Network

    November 18, 2026
    Facebook X (Twitter) Instagram
    • Home
    • Contact Us
    Benghazi DailyBenghazi Daily
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Benghazi DailyBenghazi Daily
    Home » DRC Ebola trial tests therapies as outbreak spreads
    Health

    DRC Ebola trial tests therapies as outbreak spreads

    July 8, 2026

    ITURI, DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – The Democratic Republic of the Congo has opened patient enrollment in a clinical trial for Bundibugyo virus disease as confirmed Ebola cases rose to 1,708, including 580 deaths. Government data showed the latest totals on Wednesday. The trial targets the Ebola species driving the outbreak in eastern provinces. Health authorities say no vaccine or approved specific treatment exists for this form of Ebola.

    DRC Ebola trial tests therapies as outbreak spreads
    Ebola care teams in eastern Congo face rising Bundibugyo cases.

    The PARTNERS trial will test MBP134, a monoclonal antibody, and remdesivir, an antiviral drug. Researchers will assess each therapy alone and in combination. All enrolled patients will also receive supportive care, including fluids, oxygen support, pain control, blood pressure care and electrolyte replacement. Trial teams will follow patients for at least 28 days after enrollment to track survival and clinical progress.

    The World Health Organization sponsors the trial with the Democratic Republic of the Congo’s Institut National de Recherche Biomédicale. The Institute of Tropical Medicine in Belgium and the University of Oxford also coordinate the study. Africa CDC supports the effort. The trial runs with the Ministry of Public Health, Hygiene and Social Welfare, ALIMA and Médecins Sans Frontières response teams.

    Trial targets rare Ebola species

    The outbreak involves Bundibugyo virus disease, one of the diseases caused by an Ebola virus species. Health officials confirmed the outbreak in May. The virus has spread in a region with heavy population movement, mining activity, displacement and security problems. Ituri has reported most of the cases, while North Kivu and South Kivu have also reported infections.

    WHO data from July 1 showed 1,460 confirmed cases and 452 deaths in the Democratic Republic of the Congo at that time. The toll has since increased. Earlier data also showed more than 100 infections among health and care workers. Uganda has reported linked cases, and France reported one confirmed case in a doctor who returned from the Democratic Republic of the Congo.

    Response faces security and care gaps

    Health teams continue contact tracing, laboratory testing, isolation and treatment in affected areas. WHO has described the risk in the Democratic Republic of the Congo as very high because transmission continues and cases have reached new health zones. Treatment centers face pressure from rising patient numbers. Response teams also work in areas affected by violence, mistrust and gaps in basic services.

    The trial offers a structured way to study therapies during the Ebola response. It enrolls patients of any age with confirmed Bundibugyo virus disease. Independent monitors will review study data. The platform design allows researchers to add other treatments after scientific review. For now, MBP134 and remdesivir remain the main therapies under evaluation as case numbers continue to rise.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Health

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026
    Health

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026
    Health

    WHO reports 67 yellow fever cases in nine African countries

    November 7, 2026
    Latest News

    DXB handles 50.4 million passengers in first nine months

    November 18, 2026

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Tunisia tourism revenues top $2.38 billion by end-October

    November 17, 2026

    UAE President and Venezuela’s acting leader discuss closer ties

    November 17, 2026

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    UAE and Timor-Leste presidents discuss stronger bilateral ties

    November 16, 2026

    UAE President, Arab League chief discuss regional security

    November 14, 2026

    Morocco secures €434.4 million AfDB loan for reforms

    November 14, 2026
    © 2026 Benghazi Daily | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.